Hims & Hers and Eli Lilly Announce GLP-1 Deal

• Hims & Hers has entered into a GLP-1 agreement with Eli Lilly.
• The agreement has led to a rally in Hims & Hers' stock.
• As part of the agreement, Hims & Hers will stop compounding GLP-1 medications like Zepbound.
• The deal was crucial for Hims & Hers, as indicated by its dire need for such an agreement.
• The agreement has been reported by multiple financial news outlets including MarketWatch and Barron's.